Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifedipine 80 mg vs 40 mg in Essential Hypertension
NCT01287260Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifedipine in essential hypertension, sponsored by Bayer. Started Jan 2011; status: completed.
02
Drugs
nifedipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01287260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01287260.